Peter Flanagan

981 total citations
37 papers, 319 citations indexed

About

Peter Flanagan is a scholar working on Hematology, Epidemiology and Management of Technology and Innovation. According to data from OpenAlex, Peter Flanagan has authored 37 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Epidemiology and 10 papers in Management of Technology and Innovation. Recurrent topics in Peter Flanagan's work include Blood donation and transfusion practices (10 papers), Blood transfusion and management (8 papers) and Hepatitis B Virus Studies (7 papers). Peter Flanagan is often cited by papers focused on Blood donation and transfusion practices (10 papers), Blood transfusion and management (8 papers) and Hepatitis B Virus Studies (7 papers). Peter Flanagan collaborates with scholars based in United Kingdom, New Zealand and Nigeria. Peter Flanagan's co-authors include Richard Charlewood, Mary J. Berry, T. R. O. Beringer, J. A. J. Barbara, J Cassidy, Karel Ulbrich, Aymen Al‐Shamkhani, Ruth Duncan, Leonard W. Seymour and Vladimír Šubr and has published in prestigious journals such as Journal of Hepatology, The Journal of Pathology and British Journal of Haematology.

In The Last Decade

Peter Flanagan

36 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Flanagan United Kingdom 13 78 69 56 51 48 37 319
N. A. Anderson United Kingdom 7 70 0.9× 37 0.5× 141 2.5× 35 0.7× 27 0.6× 11 392
Magdalena Łętowska Poland 11 172 2.2× 193 2.8× 137 2.4× 71 1.4× 26 0.5× 74 430
V. Brixner Germany 7 132 1.7× 88 1.3× 43 0.8× 67 1.3× 36 0.8× 16 309
Cathy Schechterly United States 9 120 1.5× 193 2.8× 41 0.7× 13 0.3× 59 1.2× 12 350
Gabriele Calizzani Italy 12 37 0.5× 39 0.6× 348 6.2× 32 0.6× 54 1.1× 27 571
Julian B. Schorr United States 10 85 1.1× 24 0.3× 120 2.1× 84 1.6× 18 0.4× 17 385
Farhat Abbas Bhatti Pakistan 7 207 2.7× 182 2.6× 109 1.9× 31 0.6× 5 0.1× 15 362
Y. Piquet France 11 108 1.4× 208 3.0× 72 1.3× 35 0.7× 25 0.5× 22 371
Pius Magesa Tanzania 8 160 2.1× 99 1.4× 325 5.8× 99 1.9× 9 0.2× 10 566
Veena Shenoy India 10 22 0.3× 17 0.2× 41 0.7× 11 0.2× 29 0.6× 35 293

Countries citing papers authored by Peter Flanagan

Since Specialization
Citations

This map shows the geographic impact of Peter Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Flanagan more than expected).

Fields of papers citing papers by Peter Flanagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Flanagan. The network helps show where Peter Flanagan may publish in the future.

Co-authorship network of co-authors of Peter Flanagan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Flanagan. A scholar is included among the top collaborators of Peter Flanagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Flanagan. Peter Flanagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hewitt, Joanne, et al.. (2018). Prevalence of hepatitis E virus antibodies and infection in New Zealand blood donors.. PubMed. 131(1469). 38–43. 18 indexed citations
2.
Murphy, Niamh, Brian O’Mahony, Peter Flanagan, et al.. (2017). Progression of hepatitis C in the haemophiliac population in Ireland, after 30 years of infection in the pre‐DAA treatment era. Haemophilia. 23(5). 712–720. 7 indexed citations
3.
Flanagan, Peter. (2017). Self‐sufficiency in plasma supply – achievable and desirable?. ISBT Science Series. 12(4). 483–487. 2 indexed citations
4.
5.
Dzik, Sunny, Michael Murphy, Meghan Delaney, et al.. (2013). Factors affecting red blood cell storage age at the time of transfusion. Transfusion. 53(12). 3110–3119. 15 indexed citations
6.
Charlewood, Richard & Peter Flanagan. (2012). Ultrio and Ultrio Plus non‐discriminating reactives: false reactives or not?. Vox Sanguinis. 104(1). 7–11. 28 indexed citations
7.
Flanagan, Peter. (2012). The ISBT code of Ethics and the altruistic donor. ISBT Science Series. 7(1). 303–306. 4 indexed citations
8.
Flanagan, Peter. (2011). How should we assess risk behaviour when determining donor deferral? Reflections on the MSM deferral. Biologicals. 40(3). 173–175. 8 indexed citations
9.
Behboodi, E., Erdoğan Memili, D. Melican, et al.. (2004). Viable Transgenic Goats Derived from Skin Cells. Transgenic Research. 13(3). 215–224. 31 indexed citations
10.
Beringer, T. R. O. & Peter Flanagan. (1999). Acute medical bed usage by nursing home residents.. PubMed. 68(1). 27–9. 14 indexed citations
11.
Flanagan, Peter & J. A. J. Barbara. (1999). PCR testing of plasma pools: From concept to reality. Transfusion Medicine Reviews. 13(3). 164–176. 12 indexed citations
12.
Flanagan, Peter & John A.J. Barbara. (1998). Consequences of Nucleic Acid Amplification Testing for Blood Transfusion Centres. Vox Sanguinis. 74(4). 265–266. 2 indexed citations
13.
Snape, Timothy J. & Peter Flanagan. (1998). Introduction of Nucleic Acid Amplification Testing of Plasma Pools – Implications for and Integrated Blood Service. Transfusion Medicine and Hemotherapy. 25(2-3). 94–97. 2 indexed citations
14.
Flanagan, Peter, et al.. (1998). An audit of anti‐D sensitisation in Yorkshire. BJOG An International Journal of Obstetrics & Gynaecology. 105(10). 1091–1094. 12 indexed citations
15.
Flanagan, Peter, et al.. (1995). Evaluation of a Combined HIV‐1/2 and HTLV‐I/II Assay for Screening Blood Donors. Vox Sanguinis. 68(4). 220–224. 12 indexed citations
16.
MacLennan, Sheila & Peter Flanagan. (1994). Prophylaxis with anti-D immunoglobulin. BMJ. 308(6922). 203.2–203.2. 3 indexed citations
17.
Irving, William L., et al.. (1993). Use of Anti‐GOR Testing in the Screening of Blood Donors for Hepatitis C Virus Infection. Vox Sanguinis. 65(1). 38–41. 4 indexed citations
18.
Seymour, Leonard W., Peter Flanagan, Aymen Al‐Shamkhani, et al.. (1991). Synthetic Polymers Conjugated to Monoclonal Antibodies: Vehicles for Tumour-Targeted Drug Delivery. PubMed. 7(2). 59–73. 32 indexed citations
19.
Flanagan, Peter, et al.. (1989). Post-transfusion hepatitis in Trent Regional Health Authority, 1988.. BMJ. 299(6700). 656–657. 4 indexed citations
20.
Flanagan, Peter, et al.. (1988). Disseminated Mycobacterium avium-intracellulare infection and red cell hypoplasia in patients with the acquired immune deficiency syndrome. Journal of Infection. 16(2). 135–140. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. A. Anderson Breakdown of academic impact, for papers by Magdalena Łętowska Breakdown of academic impact, for papers by V. Brixner Breakdown of academic impact, for papers by Cathy Schechterly Breakdown of academic impact, for papers by Gabriele Calizzani Breakdown of academic impact, for papers by Julian B. Schorr Breakdown of academic impact, for papers by Farhat Abbas Bhatti Breakdown of academic impact, for papers by Y. Piquet Breakdown of academic impact, for papers by Pius Magesa Breakdown of academic impact, for papers by Veena Shenoy
Rankless by CCL
2026